$HYEX

HEALTHY EXTRACTS INC.

Healthy Extracts develops, markets and distributes plant-based nutraceuticals for U.S. customers seeking products focused on heart, brain and immune health. Its Bergamet subsidiary offers heart and immune health supplements, including Citrus Bergamot products in tablet and capsule form under brands such as BergaMet Pro+, BergaMet Mega+O and BergaMet HERHEART. Ultimate Brain Nutrients offers brain-health products under the UBN and KETONOMICS® names, including UBN ACTIVATE and UBN RELIEF, as well as gel-pack products Brain Activate - Gel and Brain Activate - ENERGY Gel. Healthy Extracts also operates HE Gummy USA, which provides contract manufacturing, formulation and oral delivery development and manufacturing services for its own products and third parties. The company makes money by selling nutraceutical products through direct-to-consumer channels, subscriptions and retail, and by providing manufacturing and formulation services. Healthy Extracts is headquartered in Henderson, Nevada.

0
0
3

No SEC Form 4 filings for $HYEX in the last 30 days.

See all $HYEX insider activity →
Med

Healthy Extracts Secures $555,556 Convertible Note From Hinterland Partners

Healthy Extracts (HYEX) secured a $555,556 convertible note from Hinterland Partners, receiving $459,500 net. The 30-month note has 13% annual interest, monthly revenue-based payments starting March 2027, and a $2.00 conversion price. The company pledged its assets as collateral, with the agreement terminating upon a Nasdaq, NYSE, or NYSE American listing.

Healthy Extracts reports Q3 results

Healthy Extracts Inc. (HYEX) reported Q3 GAAP EPS loss of $0.12, down from $0.06 a year ago. Revenue fell 32.5% Y/Y to $619,326, with net loss widening to $1.71M from $395,394.

HEALTHY EXTRACTS INC. (HYEX): Entry into a Material Definitive Agreement

HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On November 10, 2026, we entered into a Securities Purchase Agreement whereby we issued a Secured Promissory Note in the principal amount of $555,556 to HINTERLAND PARTNERS LLC, a Delaware limited liability company (the “Holde

HYEX sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 3 news stories mentioning HYEX (HEALTHY EXTRACTS INC.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 3 bearish.

Recent HYEX coverage spans corporate actions, earnings and financial news.

What's driving HYEX

AlphAI scores every news story that mentions HYEX with an AI model for sentiment and relevance, and aggregates insider trades from HEALTHY EXTRACTS INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $HYEX

Score
$HYEXMedDebt financing· $555.56K

HEALTHY EXTRACTS INC. (HYEX): Entry into a Material Definitive Agreement

HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On November 10, 2026, we entered into a Securities Purchase Agreement whereby we issued a Secured Promissory Note in the principal amount of $555,556 to HINTERLAND PARTNERS LLC, a Delaware limited liability company (the “Holde

HEALTHY EXTRACTS INC.: Healthy Extracts' Imaraïs Health & Beauty Products Now Available at 4,000 Additional Pharmacies Nationwide

Healthy Extracts Inc. (HYEX) announced its Imaraïs Beauty products are now available at 4,000 additional pharmacies nationwide. The products, including gummies for skincare, haircare, and wellness, are clinically backed and PETA-certified. The company aims to expand in the $730 billion beauty market, with international B2B wins in the pipeline.

$HYEXLowExec change· resigned

HEALTHY EXTRACTS INC. (HYEX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 13, 2026, Bill Croyle resigned from our Board of Directors. His position, on the board and in board committees

$HYEXMedOffering· $258.75K

HEALTHY EXTRACTS INC. (HYEX): Entry into a Material Definitive Agreement

HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 hyex_ex10z1.htm SECURITIES PURCHASE AGREEMENT DATED JULY 17, 2026 Securities Purchase Agreement (Fire-Ubiquity) (00346656-5).DOCX SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 17, 2026, by and between Healthy Extrac

$HYEXLowExec change· resigned

HEALTHY EXTRACTS INC. (HYEX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. HEALTHY EXTRACTS INC. - Form 8-K SEC filing 0001630176 false 0001630176 2026-07-07 2026-07-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Dat

$HYEXMedExec change· resigned

HEALTHY EXTRACTS INC. (HYEX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

HEALTHY EXTRACTS INC. (HYEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. HEALTHY EXTRACTS INC. - Form 8-K SEC filing 0001630176 false 0001630176 2026-07-01 2026-07-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Dat

Related tickers